Evaluation of the efficacy and safety of anlotinib in postoperative non-pCR non-small cell lung cancer.

Authors: Jie Xu, Ran Zuo, Haiyan Sun, Gang Zhao, Lianmin Zhang, Bingsheng Sun, Liqun Gong, Zhanyu Pan, Zhansheng Jiang

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e20005

Source: Full article

---

Abstract

e20005